---
figid: PMC5644081__12944_2017_572_Fig1_HTML
figlink: /pmc/articles/PMC5644081/figure/Fig1/
number: F1
caption: 'NAFLD related lipotoxicity, IR and inflammation. Legend 1: Lipotoxicity
  promotes inflammation and insulin resistance (IR). In turn, IR increases adipocyte
  lipolysis and exacerbates lipotoxicity. By binding with specific receptors, saturated
  fatty acids (SFAs) activate nuclear factor-kappa B (NF-κB). In IR, liver expression
  of NF-κB is extremely high. Receptor activator of NF-κB (RANKL) binds to its receptor
  (RANK) in liver and activates the NF-κB pathway. Activation of NF-κB kinase-β (IKK-β)
  promotes expression of pro-inflammatory cytokines, such as tumor necrosis factor-alpha
  (TNF-α) and interleukin 6 (IL-6). TNF-α increases adipocyte lipolysis, strengthens
  phosphorylation of insulin receptor substrate-1(IRS-1) and reduces AMPK activity.
  IL-6 activates the c-Jun N-terminal kinase (JNK) pathway and suppresses IL-1 induced
  secretion of insulin. TNF-α and IL-6 promote development of IR and NAFLD. Defciency
  of IKK-β promotes expression of anti-inflammatory cytokines, such as adiponectin.
  Adiponectin receptor 1 (AdipoR1) activates AMPK activity, which then suppresses
  DNL, increases fatty acid oxidation and promotes mitochondrial function. AdipoR2
  activates peroxisome proliferator-activated receptor-alpha (PPAR-α) signaling, which
  exerts anti-inflammatory effects by regulating NF-κB. Adiponectin inhibits the development
  of IR and NAFLD'
pmcid: PMC5644081
papertitle: A vicious circle between insulin resistance and inflammation in nonalcoholic
  fatty liver disease.
reftext: Zhonge Chen, et al. Lipids Health Dis. 2017;16:203.
pmc_ranked_result_index: '52062'
pathway_score: 0.933089
filename: 12944_2017_572_Fig1_HTML.jpg
figtitle: NAFLD related lipotoxicity, IR and inflammation
year: '2017'
organisms:
- Homo sapiens
ndex: 6e8e27c2-df02-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5644081__12944_2017_572_Fig1_HTML.html
  '@type': Dataset
  description: 'NAFLD related lipotoxicity, IR and inflammation. Legend 1: Lipotoxicity
    promotes inflammation and insulin resistance (IR). In turn, IR increases adipocyte
    lipolysis and exacerbates lipotoxicity. By binding with specific receptors, saturated
    fatty acids (SFAs) activate nuclear factor-kappa B (NF-κB). In IR, liver expression
    of NF-κB is extremely high. Receptor activator of NF-κB (RANKL) binds to its receptor
    (RANK) in liver and activates the NF-κB pathway. Activation of NF-κB kinase-β
    (IKK-β) promotes expression of pro-inflammatory cytokines, such as tumor necrosis
    factor-alpha (TNF-α) and interleukin 6 (IL-6). TNF-α increases adipocyte lipolysis,
    strengthens phosphorylation of insulin receptor substrate-1(IRS-1) and reduces
    AMPK activity. IL-6 activates the c-Jun N-terminal kinase (JNK) pathway and suppresses
    IL-1 induced secretion of insulin. TNF-α and IL-6 promote development of IR and
    NAFLD. Defciency of IKK-β promotes expression of anti-inflammatory cytokines,
    such as adiponectin. Adiponectin receptor 1 (AdipoR1) activates AMPK activity,
    which then suppresses DNL, increases fatty acid oxidation and promotes mitochondrial
    function. AdipoR2 activates peroxisome proliferator-activated receptor-alpha (PPAR-α)
    signaling, which exerts anti-inflammatory effects by regulating NF-κB. Adiponectin
    inhibits the development of IR and NAFLD'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - REL
  - NFKB1
  - IL6
  - MAPK8
  - IL1B
  - ADIPOR1
  - RELA
  - RELB
  - ADIPOQ
  - PRKAB1
  - NFKB2
  - PRKAG2
  - PRKAG3
  - TNFSF11
  - TNF
  - MAPK9
  - MAPK10
  - IL1A
  - IKBKB
  - ADIPOR2
  - TNFRSF11A
  - PRKAB2
  - PRKAG1
  - PPARA
  - PRKAA1
  - PRKAA2
genes:
- word: NF--KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF--KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: AdipoR1
  symbol: ADIPOR1
  source: hgnc_symbol
  hgnc_symbol: ADIPOR1
  entrez: '51094'
- word: NF--KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF--KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: adiponectin
  symbol: adiponectin
  source: hgnc_alias_symbol
  hgnc_symbol: ADIPOQ
  entrez: '9370'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: NF--KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: RANKL
  symbol: RANKL
  source: hgnc_alias_symbol
  hgnc_symbol: TNFSF11
  entrez: '8600'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IL-1
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IKK-B
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: AdipoR2
  symbol: ADIPOR2
  source: hgnc_symbol
  hgnc_symbol: ADIPOR2
  entrez: '79602'
- word: RANK
  symbol: RANK
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF11A
  entrez: '8792'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: PPAR-a
  symbol: PPARA
  source: hgnc_symbol
  hgnc_symbol: PPARA
  entrez: '5465'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
chemicals: []
diseases: []
figid_alias: PMC5644081__F1
redirect_from: /figures/PMC5644081__F1
figtype: Figure
---
